Molar mass: 247.3327 g/mol
Trade name: EPH
Metabolism: Hepatic transesterification of prodrugs methylphenidate and ethanol
PubChem CID: 3080846
Ethylphenidate acts as both a dopamine reuptake inhibitor and norepinephrine reuptake inhibitor, meaning it effectively boosts the levels of the norepinephrine and dopamine neurotransmitters in the brain by binding to and partially blocking the transporter proteins that normally remove those monoamines from the synaptic cleft. This allows dopamine and norepinephrine to accumulate within the brain, resulting in stimulating and euphoric effects.